Develops instrument-free, rapid molecular point-of-care diagnostic devices
Develops instrument-free, rapid molecular point-of-care diagnostic devices. Its Veros platform uses proprietary molecular amplification technology to detect disease-related nucleic acids, delivering clinically relevant results within minutes without complex PCR temperature-cycling or fluorescence-detection hardware.